Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma

We previously identified ZNF217 as an oncogenic driver of a subset of osteosarcomas (OSAs) using the Sleeping Beauty (SB) transposon system. Here, we followed up investigating the genetic role of ZNF217 in OSA initiation and progression through establishment of a novel genetically engineered mouse m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Smeester, Branden A., Draper, Garrett M., Slipek, Nicholas J., Larsson, Alex T., Stratton, Natalie, Pomeroy, Emily J., Becklin, Kelsie L., Yamamoto, Kenta, Williams, Kyle B., Laoharawee, Kanut, Peterson, Joseph J., Abrahante, Juan E., Rathe, Susan K., Mills, Lauren J., Crosby, Margaret R., Hudson, Wendy A., Rahrmann, Eric P., Largaespada, David A., Moriarity, Branden S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290861/
https://ncbi.nlm.nih.gov/pubmed/32999043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0369
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados